Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177Lu-PSMA

Clin Nucl Med. 2024 Mar 25. doi: 10.1097/RLU.0000000000005163. Online ahead of print.ABSTRACTA 76-year-old man with castration-resistant prostate cancer underwent 68Ga-prostate-specific membrane antigen (PSMA) PET/CT for restaging. A large PSMA-avid tumor with invasion to adjacent organs was noted causing gross hematuria and symptomatic anemia. Two cycles of 177Lu-PSMA were administered, and the patient showed significant reduction of hematuria as well as declining in PSA levels. 177Lu-PSMA therapy can be a good treatment option in patients with locally invasive tumors.PMID:38537212 | DOI:10.1097/RLU.0000000000005163
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Source Type: research